Mitochondrial DNA gene therapy: a gene therapy for aging?

Konstantin Khrapko1

  • 1Gerontology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. khrapko@hms.harvard.ede

Rejuvenation Research
|March 31, 2005
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations cause rare diseases resistant to treatment. Gene therapy for these conditions may one day combat aging, but the link between mtDNA mutations and aging remains unknown.

Area of Science:

  • Mitochondrial biology
  • Genetics
  • Aging research

Background:

  • Mitochondrial DNA (mtDNA) mutations are linked to rare, treatment-resistant diseases affecting 500,000 people globally.
  • Current research explores gene therapy as a potential treatment for these mtDNA-related disorders.
  • Aging, a widespread condition affecting billions, also presents significant treatment challenges.

Purpose of the Study:

  • To investigate the potential role of mitochondrial DNA (mtDNA) mutations in the aging process.
  • To assess the feasibility of applying mitochondrial DNA (mtDNA) gene therapy strategies to aging.
  • To prioritize research into the connection between mtDNA mutations and aging.

Main Methods:

  • The abstract does not specify the methods used.
  • Further research is needed to determine the specific methodologies.

Main Results:

  • The abstract does not specify the results.
  • The contribution of mtDNA mutations to aging is currently unknown.

Conclusions:

  • Mitochondrial DNA (mtDNA) gene therapy shows promise for rare diseases and potentially for aging.
  • Establishing the link between mtDNA mutations and aging is a high-priority research goal.

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred irrespective...